Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673893 · ClinicalTrials.gov registry record
ClearWay Rx Readmission Registry
A clinical trial of Acute Myocardial Infarction, sponsored by Cardiovascular Institute of the South Clinical Research Corporation.
- Completed
- Registry status
- 59
- Enrollment target
- 1
- Study location
NCT01673893: Completed study of Acute Myocardial Infarction, sponsored by Cardiovascular Institute of the South Clinical Research Corporation.
NCT01673893 is a study of Acute Myocardial Infarction that has completed, run by Cardiovascular Institute of the South Clinical Research Corporation. The registered enrollment target is 59 participants, below the 1,879-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01673893, a study of Acute Myocardial Infarction, has completed, sponsored by Cardiovascular Institute of the South Clinical Research Corporation.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this registry is to determine if delivery of weight adjusted, in a large dose with either Abcixmab or Eptifibitide through the ClearWay™ RX, in patients admitted for primary coronary intervention lowers readmission rate. This is done in comparison to the historical control of the Medicare/Medicaid readmission database. The registry will record the use of the product during the index procedure, and determine whether or not the patient was readmitted within 30 days, related to the index procedure.
Primary Outcome
Collecting data for STEMI and NSTEMI patients for 30 day readmissions after the STEMI or NSTEMI with use of the clearway catheter during the procedure.
Conditions Studied
Interventions
- DEVICE ClearWay™ Rx catheter
Study Locations (1)
Louisiana
- Cardiovascular Institute of the South Clinical Research Corporation - Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2011-09 |
| Est. Completion | 2014-04 |
What the finished NCT01673893 record still lists
NCT01673893 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,879-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Acute Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which ClearWay™ Rx catheter is the first listed.
NCT01673893 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT01673893 about?
NCT01673893 is a clinical study titled "ClearWay Rx Readmission Registry". The purpose of this registry is to determine if delivery of weight adjusted, in a large dose with either Abcixmab or Eptifibitide through the ClearWay™ RX, in patients admitted for primary coronary intervention lowers readmission rate. This is done in comparison to the historical control of the Medi...
What is the current status of trial NCT01673893?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2011-09. Estimated completion is 2014-04.
What conditions does trial NCT01673893 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction.
What interventions are being tested in trial NCT01673893?
The interventions under investigation include: ClearWay™ Rx catheter (DEVICE).
Who is sponsoring clinical trial NCT01673893?
This trial is sponsored by Cardiovascular Institute of the South Clinical Research Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01673893 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01673893's enrollment target sits among peer trials
59 17th of 19 higher than 2 of 19 other Acute Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
RECRUITING · NA
-
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
RECRUITING
-
Abbott Vascular Medical Device Registry
RECRUITING
-
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
RECRUITING · NA
-
Arrhythmia Detection After MI
RECRUITING · NA
-
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia